The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer.

Although the case is considered exceptional, investigators are working to determine how the infection occurred and whether the pathogen played a role in the patient’s death.

The new open-source model speaks the language of DNA and can help researchers understand the effects of any changes on gene activity and health.

The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances.

WIRED was the first magazine to cover Theranos and its enticing billionaire founder. There were warning signs even then.

Some of the many variants sold today promise to penetrate our gray matter, but biology isn’t in the habit of respecting marketing declarations.